Zhang M - Search Results

1

SOX9 and HMGB3 co-operatively transactivate NANOG and promote prostate cancer progression.

Xu Y, Xu M, Li X, Weng X, Su Z, Zhang M, Tan J, Zeng H, Li X, Nie L, Gong J, Chen N, Chen X, Zhou Q. Xu Y, et al. Among authors: zhang m. Prostate. 2023 Apr;83(5):440-453. doi: 10.1002/pros.24476. Epub 2022 Dec 21. Prostate. 2023. PMID: 36541373

2

MiR200c targets IRS1 and suppresses prostate cancer cell growth.

Su W, Xu M, Chen X, Nie L, Chen N, Gong J, Zhang M, Su Z, Huang L, Zhou Q. Su W, et al. Among authors: zhang m. Prostate. 2015 Jun;75(8):855-62. doi: 10.1002/pros.22968. Epub 2015 Feb 14. Prostate. 2015. PMID: 25683382

3

Primary third ventricular tumor in an 18-year-old man.

Yu T, Zhang M, Zhou Q, Gong J, Nie L, Chen X, Chen N. Yu T, et al. Among authors: zhang m. Neuropathology. 2015 Dec;35(6):599-602. doi: 10.1111/neup.12218. Epub 2015 Jun 16. Neuropathology. 2015. PMID: 26079929 No abstract available.

4

SOX9 was involved in TKIs resistance in renal cell carcinoma via Raf/MEK/ERK signaling pathway.

Li XL, Chen XQ, Zhang MN, Chen N, Nie L, Xu M, Gong J, Shen PF, Su ZZ, Weng X, Tan JY, Zhao T, Zeng H, Zhou Q. Li XL, et al. Among authors: zhang mn. Int J Clin Exp Pathol. 2015 Apr 1;8(4):3871-81. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26097571 Free PMC article.

5

IDH1/2 gene hotspot mutations in central nervous system tumours: analysis of 922 Chinese patients.

Chen N, Yu T, Gong J, Nie L, Chen X, Zhang M, Xu M, Tan J, Su Z, Zhong J, Zhou Q. Chen N, et al. Among authors: zhang m. Pathology. 2016 Dec;48(7):675-683. doi: 10.1016/j.pathol.2016.07.010. Epub 2016 Oct 22. Pathology. 2016. PMID: 27780605

6

Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer.

Su W, Xu M, Chen X, Chen N, Gong J, Nie L, Li L, Li X, Zhang M, Zhou Q. Su W, et al. Among authors: zhang m. Mol Cancer. 2017 Aug 23;16(1):142. doi: 10.1186/s12943-017-0711-y. Mol Cancer. 2017. PMID: 28830551 Free PMC article.

7

Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α.

Zhong J, Huang R, Su Z, Zhang M, Xu M, Gong J, Chen N, Zeng H, Chen X, Zhou Q. Zhong J, et al. Among authors: zhang m. Oncotarget. 2017 May 31;8(48):83523-83538. doi: 10.18632/oncotarget.18315. eCollection 2017 Oct 13. Oncotarget. 2017. PMID: 29137361 Free PMC article.

8

MicroRNA181c inhibits prostate cancer cell growth and invasion by targeting multiple ERK signaling pathway components.

Su Z, Zhang M, Xu M, Li X, Tan J, Xu Y, Pan X, Chen N, Chen X, Zhou Q. Su Z, et al. Among authors: zhang m. Prostate. 2018 Apr;78(5):343-352. doi: 10.1002/pros.23478. Epub 2018 Jan 16. Prostate. 2018. PMID: 29341215

9

[Knocking-out of HIF1α gene by CRISPR/cas9 inhibits proliferation and invasiveness of prostate cancer DU145 cells].

Xu Y, Xu M, Zhang M, Tan J, Su Z, Chen X, Zhou Q. Xu Y, et al. Among authors: zhang m. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Apr 10;35(2):160-164. doi: 10.3760/cma.j.issn.1003-9406.2018.02.003. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018. PMID: 29652983 Chinese.

10

The Prognostic Value of the Proportion and Architectural Patterns of Intraductal Carcinoma of the Prostate in Patients with De Novo Metastatic Prostate Cancer.

Zhao J, Liu J, Sun G, Zhang M, Chen J, Shen P, Liu Z, Liao B, Zhang X, Gong J, Chen N, Zeng H; Collaborators. Zhao J, et al. Among authors: zhang m, zhang x. J Urol. 2019 Apr;201(4):759-768. doi: 10.1016/j.juro.2018.10.016. J Urol. 2019. PMID: 30652989

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62,751 results

Search Page

Filters